Webinar Includes : All the training handouts , certificate ,Q/A and 60 mins Live Webinar

Join us for a webinar on September 16 for a discussion of the webinar 

The U.S. FDA is well into their long-anticipated Unique Device Identification System. Its purpose is to “establish a system to adequately identify devices through distribution and use”. It requires the development of a unique device identifier (UDI) in plain text and machine readable formats, to be part of the labeling of every medical device. This is a multi-year phase in, based on the risk / class of the device. This New Draft Guidance expands upon the Final Rule and focuses on the two forms of a UDI and clarifies the content of the UDI, including the data delimiters that identify specific data elements within the UDI.

This is a major change for medical device manufacturers, with far-reaching effects in regulatory compliance, as envisioned by the FDA.

This Live Webinar by expert speaker John E. Lincoln, who has also published an article on UDI/GUDID for an international validation journal, will focus on the U.S. FDA’s recently released New “Unique Device Identification System: Form and Content of the Unique Device Identifier (UDI) – Draft Guidance for Industry and Food and Drug Administration Staff,”.

The session discusses the basic requirements of UDI Labeling and its database, GUDID and provides a list of key U.S. FDA publications that address UDI requirements for regulated companies and accredited agencies. It will also provide an overview of UDI / GUDID implementation schedules and discuss the required steps for UDI / GUDID compliance by medical device companies and future issues.

Webinar Takeaway

  • How the New Draft Guidance expands upon the Final Rule.
  • The two forms of a UDI and clarification on the content of the UDI
  • The data delimiters that identify specific data elements within the UDI
  • The order of the data in a UDI and UDI carrier
  • Types of acceptable formats, and its use on device labeling
  • The FDA-administered Global Unique Device Identification Database (GUDID)
  • The Draft’s definition on the expected content and forms of the UDI, for both medical device labelers and the FDA-accredited issuing agencies.
  • How the Draft will better assist compliance with the UDI Final Rule
  • The implementation schedule

Can't Make this LIVE Webinar?

Simply select the Recorded option when registering and we will send you the link to view the recorded version.

Who Will Benefit

  • Senior management in Devices and Combination products
  • QA/RA
  • CROs and Clinical personnel
  • Medical personnel and Other healthcare professionals, staff and office personnel
  • Consultants; others tasked with product, process, validations, CGMP responsibilities
  • This session is useful for members of AQC, RAPS, AAMI, etc.
  • MD3181

Industries who can attend

This 60-minute online course is intended for professionals in the Pharmaceutical, Clinical Data Management SaaS companies, and medical device companies . Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel

Faculty John E. Lincoln

John E. Lincoln


John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 36 years experience in U.S. FDA-regulated industries, 22 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files, CAPA systems and analysis.

Choose a Pricing Option

$350

Recording - Single

Recording access for ONE participant (viewer) – Unlimited viewing access for 6 months

$1,400

Recording - Corporate

Recording access (Multiple licenses) for up to 10 participants – Unlimited viewing access for 6 months